Epalrestat
Epalrestat CAS č.: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat se používá k prevenci, zlepšení a léčbě periferní neuropatie (necitlivost, bolest), vibrační parestézie a srdečních abnormalit souvisejících s cukrovkou. SPECIFIKACE
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat se používá k prevenci, zlepšení a léčbě periferní neuropatie (necitlivost, bolest), vibrační parestézie a srdečních abnormalit souvisejících s cukrovkou. SPECIFIKACE
P Název roduct | Epalrestat |
CAS | 82159-09-9 |
MF: | C15H13NO3S2 |
MW: | 319,4 |
Sem napište svoji zprávu a pošlete nám ji